Home About Us Contact Us


Table of Content - Volume 20 Issue 2 - November 2021


Study of Prevalence of Rifampicin resistance among cases of pulmonary Tuberculosis at tertiary care center


Anjali Surykant Deshmukh1, Sanjiv Vithalrao Zangde2*


1Assistant Professor, Department of Medicine, 2Assistant professor, Department of Pulmonary Medicine, Dr Shankarrao Chavan Government Medical College, Nanded, Maharashtra, INDIA.

Email: drsanjivzangde98@gmail.com



  1. Burki T. Tuberculosis-resistance, funding, and drugs. Lancet Infect Dis. 2010;10:297–298. 
  2. World Health Organization, author. Global Tuberculosis Report 2016. Geneva, Switzerland: World Health Organization; 2016. [September 2017]. Available from www.who.int/tb/publications/global_report/en/ 
  3. Falzon D, Mirzayev F, Wares F, Baena IG, Zignol M, Linh N, et al. Multidrug-resistant tuberculosis around the world: what progress has been made? Eur Respir J. 2015;45(1):150–160. 
  4. WHO (2017) Global Tuberculosis Report. World Health Organization, Geneva.
  5. Sharma SK, Kaushik G, Jha B, George N, Arora SK, et al. (2011) Prevalence of multidrug-resistant tuberculosis among newly diagnosed cases of sputum-positive pulmonary tuberculosis. Indian J Med Res 133: 308-311.
  6. Jain NK, Chopra KK, Prasad G (1992) Initial and acquired isoniazid and rifampicin resistance to Mycobacterium tuberculosis and its implication for treatment. Indian J Tuberc 39: 12-14.
  7. D’souza DT, Mistry NF, Vira TS, Dholakia Y, Hoffner S, et al. (2009) High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western India. BMC Publ Health 9: 211.
  8. Sharma SK, Kumar S, Saha PK, George N, Arora SK, et al. (2011) Prevalence of multidrug-resistant tuberculosis among Category II pulmonary tuberculosis patients. Indian J Med Res 133: 312-315.
  9. Vijay S, Bala Sangameshwara VJ, Jagannatha PS, Kumar P (2004) Initial drug resistance among tuberculosis patients under DOTS Programme in Bangalore City. Indian J Tuberc 51: 17-21.
  10. Shah AR, Agarwal SK, Shah KV (2002) Study of drug resistance in previously treated tuberculosis patients in Gujarat, India. Int J Tuberc Lung Dis 6: 1098-1101.
  11. Hanif M, Malik S, Dhingra VK (2009) Acquired drug resistance pattern in tuberculosis cases at the State Tuberculosis Centre, Delhi, India. Int J Tuberc Lung Dis 13: 74-78.
  12. Goyal V, Kadam V, Narang P, Singh V (2017) Prevalence of drug-resistant pulmonary tuberculosis in India: systematic review and meta-analysis. BMC Public Health 17: 817.
  13. Khorgade RR, Bhise PR. Role of cartridge-based nucleic acid amplification test for early diagnosis of pulmonary tuberculosis. IJAR. 2018;4(3):473-6.